Clinical Trials Directory

Trials / Completed

CompletedNCT02282501

Leptin and Ghrelin in ICU

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
özgür yağan · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Enteral alimentation is the preferred modality of support in critical patients who have acceptable digestive function and are unable to eat orally, but the advantages of continuous versus intermittent administration are surrounded by controversy. This prospective, randomised study was designed to compare two enteral feeding methods with respect to changes in levels of leptin and ghrelin in ICU.

Conditions

Interventions

TypeNameDescription
OTHERenteral feeding by nasogastric tube.method of administration enteral feeding by nasogastric tube.

Timeline

Start date
2014-08-01
Primary completion
2015-10-01
Completion
2016-02-01
First posted
2014-11-04
Last updated
2016-03-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02282501. Inclusion in this directory is not an endorsement.

Leptin and Ghrelin in ICU (NCT02282501) · Clinical Trials Directory